Corneal Transplantation: The Forgotten Graft
暂无分享,去创建一个
[1] N. Fink,et al. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. , 1995, Transplantation.
[2] J. Shadduck,et al. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens , 1980, The Journal of experimental medicine.
[3] S. Gore,et al. INFLUENCE OF DONOR AND HISTOCOMPATIBILITY FACTORS ON CORNEAL GRAFT OUTCOME , 1994, Transplantation.
[4] R. Lechler,et al. TRANSFERRIN RECEPTOR-MEDIATED GENE TRANSFER TO THE CORNEAL ENDOTHELIUM1 , 2001, Transplantation.
[5] J. Streilein. Regional immunity and ocular immune privilege. , 1999, Chemical immunology.
[6] J. Isaacs,et al. Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium , 1999, Gene Therapy.
[7] R. Marks,et al. Visual, refractive, and keratometric results of radial keratotomy. Five-year follow-up. , 1984, Archives of ophthalmology.
[8] J. Niederkorn,et al. THE DIFFERENTIAL EFFECTS OF DONOR VERSUS HOST LANGERHANS CELLS IN THE REJECTION OF MHC‐MATCHED CORNEAL ALLOGRAFTS , 1991, Transplantation.
[9] J. Pepose,et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. , 1997, The Journal of clinical investigation.
[10] R. Hendricks,et al. Identification of a novel macrophage population in the normal mouse corneal stroma. , 2002, Investigative ophthalmology & visual science.
[11] D. E. Zirm. Eine erfolgreiche totale Keratoplastik , 1906, Albrecht von Graefes Archiv für Ophthalmologie.
[12] N. Van Rooijen,et al. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. , 2000, Investigative ophthalmology & visual science.
[13] N. Joyce,et al. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. , 2002, Investigative ophthalmology & visual science.
[14] D. Roder,et al. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.
[15] D. Coster,et al. Report from the Australian Corneal Graft Registry. , 1989, Transplantation proceedings.
[16] D. Larkin. Corneal allograft rejection. , 1994, The British journal of ophthalmology.
[17] J. Isaacs,et al. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation , 2000, Clinical and experimental immunology.
[18] M. Dallman,et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea , 1997, Gene Therapy.
[19] J. Alvarado,et al. Prenatal and postnatal cellularity of the human corneal endothelium. A quantitative histologic study. , 1984, Investigative ophthalmology & visual science.
[20] D. Larkin,et al. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. , 2003, Investigative ophthalmology & visual science.
[21] G. Toews,et al. Corneal allografts fail to express Ia antigens , 1979, Nature.
[22] M. Dana,et al. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. , 2002, Investigative ophthalmology & visual science.
[23] S. Balk,et al. References Subscriptions Permissions Email Alerts NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance , 2013 .
[24] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[25] D. Larkin,et al. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. , 2001, Investigative ophthalmology & visual science.
[26] D. Hodge,et al. Ten-year postoperative results of penetrating keratoplasty. , 1998, Ophthalmology.
[27] R. Dana,et al. Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.
[28] H. Volk,et al. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4 , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[29] D. Larkin,et al. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection , 1997, Clinical and experimental immunology.
[30] M. Dana,et al. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. , 1997, Transplantation.
[31] S. Pasmans,et al. Circulating cornea-specific antibodies in corneal disease and cornea transplantation , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.
[32] D. Larkin,et al. Gene transfer to ex vivo stored corneas. , 1997, Cornea.
[33] D. Gartry,et al. Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study , 2001, The British journal of ophthalmology.
[34] K. Okumura,et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. , 1997, Transplantation.
[35] N. Lemoine,et al. Adenovirus-mediated gene delivery to the corneal endothelium. , 1996, Transplantation.
[36] A. Matas,et al. Prolongation Of Renal Allograft Survival In A Large Animal Model By Oral Rapamycin Monotherapy , 1995, Transplantation.
[37] J. Niederkorn,et al. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. , 1991, Investigative ophthalmology & visual science.
[38] I. Cree,et al. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts , 1997, Eye.
[39] D. Coster,et al. How successful is corneal transplantation? A report from the Australian corneal graft register , 1995, Eye.
[40] A. D. de Vos,et al. Cytokine mRNA expression during experimental corneal allograft rejection. , 1996, Experimental eye research.
[41] H. Dua,et al. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. , 2001, Ophthalmology.
[42] N. Joyce,et al. Effect of overexpressing the transcription factor E2F2 on cell cycle progression in rabbit corneal endothelial cells. , 2004, Investigative ophthalmology & visual science.
[43] W. M. Bourne. Cellular Changes in Transplanted Human Corneas , 2001, Cornea.
[44] P. Medawar. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.
[45] Prof. Dr. A. v. Hippel,et al. Eine neue Methode der Hornhauttransplantation , 1888, Albrecht von Graefes Archiv für Ophthalmologie.
[46] Santa Jeremy Ono,et al. A CIITA‐independent pathway that promotes expression of endogenous rather than exogenous peptides in immune‐privileged sites , 2004, European journal of immunology.
[47] D. Larkin,et al. Gene delivery to the corneal endothelium. , 2000, American journal of respiratory and critical care medicine.
[48] J. Niederkorn,et al. Effect of alloantibodies on corneal allograft survival. , 2002, Investigative ophthalmology & visual science.
[49] J. Fabre. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001; 71: 1214. , 2001 .
[50] M. B. Goren. The Eye Bank Association of America. , 2006, Comprehensive ophthalmology update.
[51] S. Bigger. An inquiry into the possibility of transplanting the cornea, with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure , 1837 .
[52] J. Niederkorn. The immune privilege of corneal allografts. , 1999, Transplantation.
[53] J. Stark,et al. Analysis of cytokine dynamics in corneal allograft rejection , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[54] J. Zieske,et al. Cell cycle protein expression and proliferative status in human corneal cells. , 1996, Investigative ophthalmology & visual science.
[55] E. Zirm. Eine erfolgreiche totale Keratoplastik (A successful total keratoplasty). 1906. , 1989, Refractive & corneal surgery.
[56] N. Ehlers,et al. OCCURRENCE OF LYMPHOCYTOTOXIC LYMPHOCYTES AND ANTIBODIES AFTER CORNEAL TRANSPLANTATION , 1976, Acta ophthalmologica.
[57] D F P Larkin,et al. Antibody targeted gene transfer to endothelium , 2003, The journal of gene medicine.
[58] D. Easty,et al. Factors influencing the suitability of organ-cultured corneas for transplantation. , 1997, Investigative ophthalmology & visual science.
[59] J. Niederkorn. Anterior chamber-associated immune deviation. , 1999, Chemical immunology.
[60] H. Thiel,et al. The use of cyclosporine in high-risk keratoplasty. , 1989, American journal of ophthalmology.
[61] D. Larkin,et al. Cytokine and chemokine expression kinetics after corneal transplantation. , 2000, Transplantation.
[62] D. Easty,et al. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. , 1991, Investigative ophthalmology & visual science.
[63] D. Coster,et al. Rethinking immunological privilege: implications for corneal and limbal stem cell transplantation. , 1997, Molecular medicine today.
[64] K. Teichmann. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection , 1999, The British journal of ophthalmology.
[65] Andrew D Dick,et al. Predicting endothelial cell loss and long-term corneal graft survival. , 2003, Investigative ophthalmology & visual science.
[66] K. Sonoda,et al. Ocular Immune Privilege and CD1d-Reactive Natural Killer T Cells , 2002, Cornea.
[67] P. Trevor-Roper,et al. Organization and administration of Westminster-Moorfields Eye-Bank. , 1967, The British journal of ophthalmology.
[68] D. Larkin,et al. Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium , 2000, Cornea.
[69] D. Larkin,et al. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. , 2002, Investigative ophthalmology & visual science.